| HFQDX | TRWTX | HFQDX / TRWTX | |
| Total Expense Ratio | 0.85 | 0.76 | 112% |
| Annual Report Gross Expense Ratio | 0.85 | 0.76 | 112% |
| Fund Existence | 9 years | 34 years | - |
| Gain YTD | 18.606 | 18.554 | 100% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.92B | 4.41B | 180% |
| Annual Yield % from dividends | 6.09 | 3.32 | 183% |
| Returns for 1 year | 25.89 | 23.42 | 111% |
| Returns for 3 years | 77.65 | 69.32 | 112% |
| Returns for 5 years | 78.04 | 58.53 | 133% |
| Returns for 10 years | N/A | 111.88 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SBHIX | 29.21 | 0.28 | +0.97% |
| Saratoga Health & Biotechnology I | |||
| GQJPX | 12.86 | 0.08 | +0.63% |
| GQG Partners Intl Qual Val Fd Inv | |||
| PNOPX | 129.71 | 0.63 | +0.49% |
| Putnam Sustainable Leaders A | |||
| GRMAX | 34.21 | 0.15 | +0.44% |
| Nationwide S&P 500 Index A | |||
| TNRAX | 23.07 | 0.09 | +0.40% |
| 1290 Avantis U.S. Large Cap Growth A | |||